Biotech RadarJobs updated

COMPANY

Koya Medical

HQ: Dallas, TX source · koyamedical.com ↗

FDA-cleared device company

Location: Dallas, TX · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Lymphedema Chronic Venous Insufficiency Phlebolymphedema Lymphedema Lower Extremity Secondary Lymphedema Lymphedema of Leg Venous Insufficiency Lower Limb Lymphedema Edema Venous Insufficiency of Leg Breast Cancer Related Lymphedema Quality of Life Dayspring Active Wearable Compression System Dayspring

7Trials (company is sponsor)

Timeline

  1. Trial start Not phased (device or behavioral study): Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema source ↗
  2. Trial start —: A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Insight® Pro Device for Evaluating Lymphatic and Venous Disorders (VOLGA) source ↗
  3. Trial start Not phased (device or behavioral study): A Clinical Study to Evaluate the Effectiveness of a Novel Portable Non-Pneumatic Active Compression Device vs. an Advanced Pneumatic Compression Device for Treating Lower Extremity Lymphedema source ↗
  4. Trial start Not phased (device or behavioral study): Study to Evaluate the Safety and Effectiveness of Dayspring for Lower Extremity Lymphedema source ↗
  5. Trial start Not phased (device or behavioral study): A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Tr source ↗
  6. Trial start Not phased (device or behavioral study): A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery source ↗
  7. Trial start Not phased (device or behavioral study): Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled Study source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 7

RecordTitlePhaseStatusStartPrimary completion
NCT06418282Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/PhlebolymphedemaNot phased (device or behavioral study)RecruitingMay 13, 2024Dec 31, 2027 (estimated)
NCT04897035Study to Evaluate the Safety and Effectiveness of Dayspring for Lower Extremity LymphedemaNot phased (device or behavioral study)CompletedJun 1, 2021Jun 30, 2022 (actual)
NCT05507346A Clinical Study to Evaluate the Effectiveness of a Novel Portable Non-Pneumatic Active Compression Device vs. an Advanced Pneumatic Compression Device for Treating Lower Extremity LymphedemaNot phased (device or behavioral study)CompletedSep 6, 2022Jan 9, 2024 (actual)
NCT05628688A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Insight® Pro Device for Evaluating Lymphatic and Venous Disorders (VOLGA)Not listedCompletedAug 8, 2023Aug 28, 2024 (actual)
NCT04908254A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related LymphedemaNot phased (device or behavioral study)CompletedJun 1, 2021Dec 31, 2021 (actual)
NCT04659564Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled StudyNot phased (device or behavioral study)CompletedAug 5, 2020May 28, 2021 (actual)
NCT04888975A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic SurgeryNot phased (device or behavioral study)RecruitingJun 1, 2021Dec 31, 2021 (estimated)
Feedback